Global Gene Therapy for Ovarian Cancer Market Research Report 2022

Market Analysis and Insights: Global Gene Therapy for Ovarian Cancer Market

Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has already got some commercially successful chemotherapy products. However, chemotherapy often involves a combination of two or more drugs, given intravenously every 3-4 weeks, and mostly associated with long-lasting side/adverse effects. Various studies have shown that chemotherapy can damage the blood-producing cells of the bone marrow, resulting in blood-related complications.

The global Gene Therapy for Ovarian Cancer market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Gene therapy is expected to be one of the next big paradigm shift in pharmacology due to the extensive on-going research studies, both at academic and industry level. Gene therapy is one of the most exciting approaches for the treatment of ovarian cancer. Replacement gene therapy is gaining attention as it has the potential to cure ovarian cancer and can be used as a promising option for long-lasting treatment.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy for Ovarian Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy for Ovarian Cancer market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy for Ovarian Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy for Ovarian Cancer market.

Global Gene Therapy for Ovarian Cancer Scope and Market Size

Gene Therapy for Ovarian Cancer market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gene Therapy for Ovarian Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Intravenous

Intratumoral

Intraperitoneal

Ovarian Cancer (Unspecified)

Recurrent Ovarian Epithelial Cancer

Platinum-Resistant Ovarian Cancer

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Takara Bio

VBL Therapeutics

CELSION

Targovax

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Intravenous

1.2.3 Intratumoral

1.2.4 Intraperitoneal

1.3 Market by Application

1.3.1 Global Gene Therapy for Ovarian Cancer Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Ovarian Cancer (Unspecified)

1.3.3 Recurrent Ovarian Epithelial Cancer

1.3.4 Platinum-Resistant Ovarian Cancer

1.4 Study Objectives

1.5 Years Considered

2.1 Global Gene Therapy for Ovarian Cancer Market Perspective (2017-2028)

2.2 Gene Therapy for Ovarian Cancer Growth Trends by Region

2.2.1 Gene Therapy for Ovarian Cancer Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Gene Therapy for Ovarian Cancer Historic Market Size by Region (2017-2022)

2.2.3 Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2023-2028)

2.3 Gene Therapy for Ovarian Cancer Market Dynamics

2.3.1 Gene Therapy for Ovarian Cancer Industry Trends

2.3.2 Gene Therapy for Ovarian Cancer Market Drivers

2.3.3 Gene Therapy for Ovarian Cancer Market Challenges

2.3.4 Gene Therapy for Ovarian Cancer Market Restraints

3.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue

3.1.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue (2017-2022)

3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Players (2017-2022)

3.2 Global Gene Therapy for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Therapy for Ovarian Cancer Revenue

3.4 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio

3.4.1 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Ovarian Cancer Revenue in 2021

3.5 Gene Therapy for Ovarian Cancer Key Players Head office and Area Served

3.6 Key Players Gene Therapy for Ovarian Cancer Product Solution and Service

3.7 Date of Enter into Gene Therapy for Ovarian Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Type (2017-2022)

4.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2023-2028)

5.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Application (2017-2022)

5.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2023-2028)

6.1 North America Gene Therapy for Ovarian Cancer Market Size (2017-2028)

6.2 North America Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)

6.3 North America Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7.1 Europe Gene Therapy for Ovarian Cancer Market Size (2017-2028)

7.2 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)

7.3 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8.1 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size (2017-2028)

8.2 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)

8.3 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9.1 Latin America Gene Therapy for Ovarian Cancer Market Size (2017-2028)

9.2 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)

9.3 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10.1 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size (2017-2028)

10.2 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)

10.3 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11.1 Takara Bio

11.1.1 Takara Bio Company Detail

11.1.2 Takara Bio Business Overview

11.1.3 Takara Bio Gene Therapy for Ovarian Cancer Introduction

11.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022)

11.1.5 Takara Bio Recent Development

11.2 VBL Therapeutics

11.2.1 VBL Therapeutics Company Detail

11.2.2 VBL Therapeutics Business Overview

11.2.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Introduction

11.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022)

11.2.5 VBL Therapeutics Recent Development

11.3 CELSION

11.3.1 CELSION Company Detail

11.3.2 CELSION Business Overview

11.3.3 CELSION Gene Therapy for Ovarian Cancer Introduction

11.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022)

11.3.5 CELSION Recent Development

11.4 Targovax

11.4.1 Targovax Company Detail

11.4.2 Targovax Business Overview

11.4.3 Targovax Gene Therapy for Ovarian Cancer Introduction

11.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022)

11.4.5 Targovax Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Key Players of Intravenous

    Table 3. Key Players of Intratumoral

    Table 4. Key Players of Intraperitoneal

    Table 5. Global Gene Therapy for Ovarian Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 6. Global Gene Therapy for Ovarian Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Gene Therapy for Ovarian Cancer Market Size by Region (2017-2022) & (US$ Million)

    Table 8. Global Gene Therapy for Ovarian Cancer Market Share by Region (2017-2022)

    Table 9. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 10. Global Gene Therapy for Ovarian Cancer Market Share by Region (2023-2028)

    Table 11. Gene Therapy for Ovarian Cancer Market Trends

    Table 12. Gene Therapy for Ovarian Cancer Market Drivers

    Table 13. Gene Therapy for Ovarian Cancer Market Challenges

    Table 14. Gene Therapy for Ovarian Cancer Market Restraints

    Table 15. Global Gene Therapy for Ovarian Cancer Revenue by Players (2017-2022) & (US$ Million)

    Table 16. Global Gene Therapy for Ovarian Cancer Market Share by Players (2017-2022)

    Table 17. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2021)

    Table 18. Ranking of Global Top Gene Therapy for Ovarian Cancer Companies by Revenue (US$ Million) in 2021

    Table 19. Global 5 Largest Players Market Share by Gene Therapy for Ovarian Cancer Revenue (CR5 and HHI) & (2017-2022)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Gene Therapy for Ovarian Cancer Product Solution and Service

    Table 22. Date of Enter into Gene Therapy for Ovarian Cancer Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Gene Therapy for Ovarian Cancer Market Size by Type (2017-2022) & (US$ Million)

    Table 25. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2017-2022)

    Table 26. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 27. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2023-2028)

    Table 28. Global Gene Therapy for Ovarian Cancer Market Size by Application (2017-2022) & (US$ Million)

    Table 29. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2017-2022)

    Table 30. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 31. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2023-2028)

    Table 32. North America Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)

    Table 33. North America Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)

    Table 34. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)

    Table 35. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)

    Table 36. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2017-2022) & (US$ Million)

    Table 37. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2023-2028) & (US$ Million)

    Table 38. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)

    Table 39. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)

    Table 40. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)

    Table 41. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)

    Table 42. Takara Bio Company Detail

    Table 43. Takara Bio Business Overview

    Table 44. Takara Bio Gene Therapy for Ovarian Cancer Product

    Table 45. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022) & (US$ Million)

    Table 46. Takara Bio Recent Development

    Table 47. VBL Therapeutics Company Detail

    Table 48. VBL Therapeutics Business Overview

    Table 49. VBL Therapeutics Gene Therapy for Ovarian Cancer Product

    Table 50. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022) & (US$ Million)

    Table 51. VBL Therapeutics Recent Development

    Table 52. CELSION Company Detail

    Table 53. CELSION Business Overview

    Table 54. CELSION Gene Therapy for Ovarian Cancer Product

    Table 55. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022) & (US$ Million)

    Table 56. CELSION Recent Development

    Table 57. Targovax Company Detail

    Table 58. Targovax Business Overview

    Table 59. Targovax Gene Therapy for Ovarian Cancer Product

    Table 60. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022) & (US$ Million)

    Table 61. Targovax Recent Development

    Table 62. Research Programs/Design for This Report

    Table 63. Key Data Information from Secondary Sources

    Table 64. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2021 VS 2028

    Figure 2. Intravenous Features

    Figure 3. Intratumoral Features

    Figure 4. Intraperitoneal Features

    Figure 5. Global Gene Therapy for Ovarian Cancer Market Share by Application in 2021 & 2028

    Figure 6. Ovarian Cancer (Unspecified) Case Studies

    Figure 7. Recurrent Ovarian Epithelial Cancer Case Studies

    Figure 8. Platinum-Resistant Ovarian Cancer Case Studies

    Figure 9. Gene Therapy for Ovarian Cancer Report Years Considered

    Figure 10. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 11. Global Gene Therapy for Ovarian Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Gene Therapy for Ovarian Cancer Market Share by Region: 2021 VS 2028

    Figure 13. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2021

    Figure 14. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2021

    Figure 16. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 17. North America Gene Therapy for Ovarian Cancer Market Share by Country (2017-2028)

    Figure 18. United States Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 19. Canada Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Europe Gene Therapy for Ovarian Cancer Market Share by Country (2017-2028)

    Figure 22. Germany Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 23. France Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 24. U.K. Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 25. Italy Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. Russia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. Nordic Countries Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Region (2017-2028)

    Figure 30. China Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. South Korea Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 33. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 34. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 35. Australia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Latin America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Latin America Gene Therapy for Ovarian Cancer Market Share by Country (2017-2028)

    Figure 38. Mexico Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Brazil Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Country (2017-2028)

    Figure 42. Turkey Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 43. Saudi Arabia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 44. Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2017-2022)

    Figure 45. VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2017-2022)

    Figure 46. CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2017-2022)

    Figure 47. Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2017-2022)

    Figure 48. Bottom-up and Top-down Approaches for This Report

    Figure 49. Data Triangulation

    Figure 50. Key Executives Interviewed